Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Akarx Drug Patent Portfolio

Akarx owns 2 orange book drugs protected by 3 US patents Given below is the list of Akarx's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7638536 2-Acylaminothiazole derivative or salt thereof 28 Jul, 2027
Active
US8338429 2-acylaminothiazole derivative or salt thereof 30 Jun, 2023 Expired
US8765764 2-acylaminothiazole derivative or salt thereof 15 Jan, 2023 Expired


Given below is the list of recent legal activities going on the following drug patents of Akarx.

Activity Date Patent Number
Patent litigations
Expire Patent 27 Jan, 2025 US8338429
Maintenance Fee Reminder Mailed 12 Aug, 2024 US8338429
Patent Term Extension Certificate 08 Jan, 2024 US7638536
Patent Term Extension Certificate
Critical
08 Jan, 2024 US7638536
Resp. to req. for info. sent under 37 CFR 1.750 26 Dec, 2023 US7638536
Resp. to req. for info. sent under 37 CFR 1.750 26 Dec, 2023 US7638536
Requirement for information sent under 37 CFR 1.750 08 Dec, 2023 US7638536
Requirement for information sent under 37 CFR 1.750 08 Dec, 2023 US7638536
Notice of Final Determination -Eligible 16 Nov, 2023 US7638536
Notice of Final Determination -Eligible 16 Nov, 2023 US7638536
FDA Final Eligibility Letter 14 Nov, 2023 US7638536
FDA Final Eligibility Letter
Critical
14 Nov, 2023 US7638536
transaction for FDA Determination of Regulatory Review Period 06 Feb, 2023 US7638536
transaction for FDA Determination of Regulatory Review Period 06 Feb, 2023 US7638536
Information Disclosure Statement (IDS) Filed
Critical
02 Feb, 2023 US7638536


Akarx's Family Patents

Akarx drugs have patent protection in a total of 15 countries. It's US patent count contributes only to 16.7% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Akarx Drug List

Given below is the complete list of Akarx's drugs and the patents protecting them.


1. Doptelet

Doptelet is protected by 3 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7638536 2-Acylaminothiazole derivative or salt thereof 28 Jul, 2027
(1 year, 3 months from now)
Active
US8338429 2-acylaminothiazole derivative or salt thereof 30 Jun, 2023
(2 years ago)
Expired
US8765764 2-acylaminothiazole derivative or salt thereof 15 Jan, 2023
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Doptelet's drug page


2. Doptelet Sprinkle

Doptelet Sprinkle is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7638536 2-Acylaminothiazole derivative or salt thereof 28 Jul, 2027
(1 year, 3 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Doptelet Sprinkle's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List